Clinical Study On Lower Limb Robot For Lower Limb Dysfunction After Stroke

May 28, 2023 updated by: liuyong
The goal of this clinical trial is to learn about effect of lower robot in stroke population. The main question[s] it aims to answer are: the efficacy of lower limb robot assisted training in improving walking ability, lower limb function, cognition, and quality of life in stroke patients.The robot group of patients received lower limb robot assisted training combined with routine rehabilitation treatment. The control group only received routine rehabilitation treatment.Compare two groups to explore the therapeutic effect of lower limb robots on lower limb dysfunction after stroke.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

18

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Liaoning
      • Dalian, Liaoning, China, 116011
        • Recruiting
        • The First Affiliated Hospital of Dalian Medical University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • In line with the diagnostic criteria for stroke in the Diagnostic Criteria for Various Cerebrovascular Diseases issued by the Chinese Medical Association in 2019.
  • First stroke or no residual dysfunction after previous stroke.
  • Participants have stable vital signs, clear consciousness, and no aphasia.
  • The onset time of stroke is between 2 weeks and 6 months after onset.
  • Age>18 years old.
  • Presence of hemiplegic motor dysfunction.
  • Ability to walk with the help of a single person.
  • sign an informed consent form with the Participants or family member before treatment.

Exclusion Criteria:

  • Participants have serious musculoskeletal or other mental nervous system disease.
  • Participants have contraindications to cardiovascular exercise.
  • Moderate to severe contracture of the patient's lower limbs (modified Ashworth scale, MAS>2 for ankle, knee, or hip joints).
  • Presence of progressive or secondary brain injury leading to unstable condition.
  • Unilateral neglect or diseases that affect vision.
  • Participants have lower limb vein thrombosis.
  • Participants present with lower limb non healing ulcers and osteoporosis.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: robot group
The participants in the robot group received lower limb robot assisted walking training combined with routine rehabilitation therapy. Routine rehabilitation therapy includes lower limb muscle strength training, stretching training, joint range of motion training, balance training, walking training, and functional electrical stimulation.
The participants in the robot group received lower limb robot assisted walking training combined with routine rehabilitation therapy. Lower limb robot assisted walking training for 30 minutes each time, once a day, 5 times a week, for 4 consecutive weeks; Routine rehabilitation treatment includes lower limb muscle strength training, stretching training, joint range of motion training, balance training, walking training, functional electrical stimulation, etc. Routine rehabilitation treatment once a day, five times a week, for four consecutive weeks.
Active Comparator: control group
Routine rehabilitation therapy includes lower limb muscle strength training, stretching training, joint range of motion training, balance training, walking training, and functional electrical stimulation.
The control group participants received routine rehabilitation, including lower limb muscle strength training, stretching training, joint range of motion training, balance training, walking training, functional electrical stimulation, etc. Routine rehabil

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from Baseline Berg Balance Scale at 4 weeks
Time Frame: baseline and 4 weeks
The Berg Balance Scale is a commonly used scale for evaluating balance ability in stroke Participants.Participants cooperate to complete the corresponding projects, and specialized assessors with professional knowledge in rehabilitation assessment will score based on the patient's completion status. The scale has a total of 14 items, including standing up from a sitting position, standing to sitting, standing independently, sitting independently, bed to wheelchair transfer, standing with eyes closed, standing with feet together, standing with upper limbs extended forward, standing with objects picked up from the ground, turning back to look, turning around for a week, alternating steps with both feet, standing with both feet in front of and behind, and standing with one leg. Each project has a maximum score of 4 and a ,minimum score of 0. The higher the score, the better the balance ability.
baseline and 4 weeks
Change from Baseline functional ambulation category scale at 4 weeks
Time Frame: baseline and 4 weeks
The functional ambulation category scale is a commonly used scale for evaluating walking ability, with ratings ranging from 0 to 5. The higher the level, the better the walking ability.
baseline and 4 weeks
Change from Baseline fugl-meyer assessment-lower extremity at 4 weeks
Time Frame: baseline and 4 weeks
The scale assesses the presence or absence of reflexes in the participants' lower limbs, as well as the presence of hyperreflexia, flexor coordination, extensor coordination, activities accompanied by coordination, activities without coordination, and speed.The higher the score, the better the lower limb motor ability
baseline and 4 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from Baseline modified barthel index at 4 weeks
Time Frame: baseline and 4 weeks
The evaluators rated participants on items such as grooming, bathing, eating, toileting, dressing, bowel control, urination control, going up and down stairs, bed and chair transfer, and walking on level ground. The higher the score, the better the daily living ability.
baseline and 4 weeks
Change from Baseline Gait parameters at 4 weeks
Time Frame: baseline and 4 weeks
Use a gait analysis device to measure the patient's walking speed, stride frequency, stride length, and stride length. The linear distance traveled in the direction of travel per unit time during walking at a pace. Step frequency refers to the number of steps taken per minute during walking. Step length refers to the distance traveled by one foot following the ground during walking to the next foot following the ground. When walking, the distance traveled from one foot following the ground to another heel landing on that side.
baseline and 4 weeks
Change from Baseline Minimum Mental State Examination at 4 weeks
Time Frame: baseline and 4 weeks
This scale is a commonly used scale for evaluating participants' cognitive status. Participants are required to answer the corresponding questions or complete the corresponding actions according to the instructions. If the answer is correct or the corresponding actions are completed, 1 point will be awarded, otherwise no point will be awarded. The total score is 30 points, and the higher the score, the better the cognitive ability.
baseline and 4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2023

Primary Completion (Estimated)

January 1, 2024

Study Completion (Estimated)

May 1, 2024

Study Registration Dates

First Submitted

May 18, 2023

First Submitted That Met QC Criteria

May 28, 2023

First Posted (Actual)

May 31, 2023

Study Record Updates

Last Update Posted (Actual)

May 31, 2023

Last Update Submitted That Met QC Criteria

May 28, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Lower limb robot assisted walking training

Subscribe